Paris has imposed strict penalties on Opella, a paracetamol manufacturer, to ensure it maintains production and jobs in France following its acquisition by US firm CD&R. The agreement includes a €40 million penalty for halting production at key factories and a €100 million fine for not sourcing paracetamol ingredients from a future French facility. The French government will also invest up to €150 million in Opella to secure oversight of its operations.
The French government has secured strong guarantees in the sale of a 50% stake in Opella, producer of Doliprane, to American investment fund CD & R, which aims to enhance growth. The agreement includes a €70 million investment in France, job protection, and penalties for production stoppages. Sanofi retains a 48% stake, ensuring continued involvement in Opella's operations.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
